d1000 Varejo Farma Participações Balance Sheet Health
Financial Health criteria checks 5/6
d1000 Varejo Farma Participações has a total shareholder equity of R$893.2M and total debt of R$21.6M, which brings its debt-to-equity ratio to 2.4%. Its total assets and total liabilities are R$1.7B and R$827.6M respectively. d1000 Varejo Farma Participações's EBIT is R$68.7M making its interest coverage ratio 2.3. It has cash and short-term investments of R$39.2M.
Key information
2.4%
Debt to equity ratio
R$21.57m
Debt
| Interest coverage ratio | 2.3x |
| Cash | R$39.21m |
| Equity | R$893.21m |
| Total liabilities | R$827.58m |
| Total assets | R$1.72b |
Recent financial health updates
Recent updates
Is d1000 Varejo Farma Participações (BVMF:DMVF3) A Risky Investment?
Nov 27
d1000 Varejo Farma Participações S.A.'s (BVMF:DMVF3) Share Price Matching Investor Opinion
Oct 15d1000 Varejo Farma Participações S.A.'s (BVMF:DMVF3) Popularity With Investors Is Clear
Apr 19Returns Are Gaining Momentum At d1000 Varejo Farma Participações (BVMF:DMVF3)
Oct 31d1000 Varejo Farma Participações (BVMF:DMVF3) Shareholders Will Want The ROCE Trajectory To Continue
Jul 13Earnings Not Telling The Story For d1000 Varejo Farma Participações S.A. (BVMF:DMVF3)
May 13Investors Shouldn't Be Too Comfortable With d1000 Varejo Farma Participações' (BVMF:DMVF3) Robust Earnings
Aug 18d1000 Varejo Farma Participações (BVMF:DMVF3) Shareholders Will Want The ROCE Trajectory To Continue
Oct 29Financial Position Analysis
Short Term Liabilities: DMVF3's short term assets (R$543.0M) exceed its short term liabilities (R$479.5M).
Long Term Liabilities: DMVF3's short term assets (R$543.0M) exceed its long term liabilities (R$348.1M).
Debt to Equity History and Analysis
Debt Level: DMVF3 has more cash than its total debt.
Reducing Debt: DMVF3's debt to equity ratio has reduced from 70.5% to 2.4% over the past 5 years.
Debt Coverage: DMVF3's debt is well covered by operating cash flow (749%).
Interest Coverage: DMVF3's interest payments on its debt are not well covered by EBIT (2.3x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 21:39 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
d1000 Varejo Farma Participações S.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Georgia Jorge | BB Banco de Investimento S.A. |
| Mariana Ferraz Costa Zanini | Eleven Financial Research |
| Jennie Li | XP Investimentos |